乌鸦传媒

Dermatology

<乌鸦传媒 class='mpt-top_cat_title_description'>News, opinions and meeting coverage in dermatology.

<乌鸦传媒>AAD: Frog Enzyme Clears Genital Warts

Summaries of late-breaking research from the dermatology meeting.

<乌鸦传媒>Finasteride for Hair Loss: Some Risk for Sexual Dysfunction

Younger men who use the baldness drug see small but still significant chance for impotence, diminished libido.

<乌鸦传媒>Psoriasis and Tonsillectomy: A Real Head Scratcher

Skin disease often improves after surgery but no one knows why.

<乌鸦传媒>Fat-Lysing Agent Makes Double Chin Disappear

Consistent results seen with injection of synthetic deoxycholic acid compound.

<乌鸦传媒>Acne Improves Without Use of Antibiotics

Topical adapalene/benzoyl peroxide reduced lesion counts up to 75%.

<乌鸦传媒>IL-17 Inhibitor Clears Psoriasis More Often

Brodalumab twice as likely to clear all lesions as ustekinumab.

<乌鸦传媒>Novel IL-23 Inhibitor Shows Promise in Psoriasis

Interleukin-23 inhibitor has 'high efficacy, quiet safety signal.'

<乌鸦传媒>Future of Dermatology on Display at AAD

Program to reflect challenges to practice, scientific advances.

<乌鸦传媒>Gross Anatomy: Rare Alga Growth From Human Tissue Sample

The culture was negative, so what's all this green stuff?

<乌鸦传媒>Cosentyx Gets FDA Nod for Psoriasis

Anti-IL17 drug secukinumab OK'd for moderate-to-severe disease.

<乌鸦传媒>Make the Diagnosis: Back Lesion Worries Derm's Wife

A middle-aged couple comes into your office. The wife is concerned about a strange looking growth on her husbands upper back that she feels has been stable for the past two years. She tells you that her husband is a dermatologist, but rarely uses sunscreen despite all the advice he gives his patients. The husband tells you that he would like to be a back model again someday if you could just get rid of this growth. What's your diagnosis?

<乌鸦传媒>Antibodies Predict Scleroderma Renal Crisis

Antibody test aids assessing risk for this potentially lethal complication.

<乌鸦传媒>Otezla Benefit Durable in PsA

Benefits persist through 2 years with apremilast in psoriatic arthritis.

<乌鸦传媒>Joints Tell the Future in Scleroderma

Synovitis predicted progression in skin, vasculature, and kidney.

<乌鸦传媒>Derms Want NP/PA Practice Limits

NPs and PAs who bill Medicaid as independent practitioners are more likely to bill for a dermatology visit than for any other office-based service -- so much so that in 2012, 55% of their Medicaid billings were for derm codes, to which dermatologists claim scope of practice violations.

<乌鸦传媒>New Melanomas Likely to Recur at Same Rate

CHICAGO -- A diagnosis of in situ or invasive melanoma conferred a similar long-term risk of invasive melanoma recurrence, a 40-year retrospective review showed.

<乌鸦传媒>Smoking Worsens Psoriatic Arthritis

Patients with psoriatic arthritis who smoke have worse patient-reported disease features at baseline and don't respond as well as nonsmokers to anti-tumor necrosis factor (TNF) treatment, a Danish study found.

<乌鸦传媒>Estrogen Alone May Not Suppress Testosterone

CHICAGO -- Simply giving estrogen to male-to-female transgender patients won't completely suppress testosterone levels, researchers reported here.

<乌鸦传媒>AMA Clamps Down on MOC, But Punts on Gun Regs

CHICAGO -- The AMA鈥檚 House of Delegates drew the line on this year's hot button topic -- maintenance of certification (MOC), saying it should not be mandatory, nor should it be a condition of licensure.

<乌鸦传媒>ASCO: Targeting PD-1 Works in Advanced Melanoma

CHICAGO -- Two studies indicate that using investigative immunotherapy drugs improves survival and response in patients with metastatic melanoma, researchers said here.

<乌鸦传媒>ASCO: Ipilimumab Cuts Relapse but Safety Issues Remain

CHICAGO -- High-risk melanoma patients have a reduced level of relapse if they are taking the monoclonal antibody ipilimumab (Yervoy) when compared with placebo, researchers said here.

<乌鸦传媒>OncoBriefs: Myeloma Tx, In Situ Melanoma

Superficial melanoma conferred a risk of recurrent invasive melanoma similar to that of primary invasive melanoma, Australian investigators reported. The study is one of several oncology-related news items summarized in OncoBriefs.

<乌鸦传媒>Severe Eczema Eases with Novel Biologic

SAN DIEGO -- The novel monoclonal antibody dupilumab dramatically cut the severity of moderate-to-severe adult atopic dermatitis, a phase II trial showed.

<乌鸦传媒>Medtronic Sued by 1,000 Infuse Patients

Medtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 product, Infuse, and that many more lawsuits may be coming.

<乌鸦传媒>Bodybuilders Bulk Up Using ... Cancer Drugs?

While steroids are all-stars among performance-enhancing drugs, breast cancer drugs are a lesser-known staple of doping regimens, as are some investigational agents that aren't available on any regulated market.

<乌鸦传媒>Prime Time: Skin Docs Name 5 Unnecessary Procedures

The American Academy of Dermatology joined more than 80 other medical societies in the Choosing Wisely campaign, naming five treatments or procedures that may not be necessary. Prime Time is a blog by Chris Kaiser for those interested in primary care.

<乌鸦传媒>Antidepressants, Lyrica OK Combo in Fibromyalgia

SAN DIEGO -- Patients with fibromyalgia who were taking antidepressants found that their pain was successfully managed with pregabalin (Lyrica), a researcher said here.

<乌鸦传媒>Few Lupus, IBD Patients Getting HPV Vaccine

SAN DIEGO -- Despite being at greater risk of infection, few children and young adults with autoimmune diseases are being vaccinated against human papillomavirus, according to a study.

<乌鸦传媒>Losing a Tattoo, Gaining a Tumor

An unintended consequence of laser tattoo removal in a 29-year-old man was a diagnosis of malignant melanoma, according to a German case report.

<乌鸦传媒>Wounds Heal Better When Debrided Often

Faster and more complete wound healing was achieved with more frequent debridement regardless of wound type, size, or duration, researchers found.

<乌鸦传媒>Itching: No Big Deal in Most Cases But ...

Summer usually brings with it plenty of causes for itching, most of which are annoying but not indicative of serious health problems.

<乌鸦传媒>Medicare to Pay for More FDG-PET Scans

WASHINGTON -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid Services said.

<乌鸦传媒>ASCO: Herpes-Derived Tx for Melanoma?

CHICAGO -- Intralesional injection of an oncolytic therapy significantly increased the durable response rate in advanced melanoma compared with a control therapy, according to results of a randomized trial.

<乌鸦传媒>ASCO: Immune Therapy Durable in Melanoma

CHICAGO -- A therapy aimed at reviving the immune response to advanced melanoma generated durable responses in long-term follow-up of an early clinical trial, a researcher said here.

<乌鸦传媒>Tattoo Me: Tales of Regret and No Regrets

MIAMI BEACH -- Almost a third of people with tattoos regretted the decision to get body art, particularly men who obtained tattoos at a young age, a survey of more than 500 tattoo owners showed.

<乌鸦传媒>Lichen Planus in Ear Not Uncommon

MIAMI BEACH -- The autoimmune disease lichen planus may affect the ear more commonly than previously thought, researchers reported here.

<乌鸦传媒>UVB Exposure May Boost Low Vitamin D

MIAMI BEACH -- Narrowband UVB therapy may be a better treatment for vitamin D deficiency than supplementation, Swedish researchers reported here.

<乌鸦传媒>Novel Drug Works in Psoriasis

MIAMI BEACH -- An investigational phosphodiestirase-4 (PDE4) inhibitor may improve psoriasis, particularly in patients who haven't previously been treated, researchers reported here.

<乌鸦传媒>IL-4 Antibody Tames Atopic Dermatitis

MIAMI BEACH -- Atopic dermatitis disease activity declined significantly in patients treated with a monoclonal antibody directed against interleukin-4, according to pooled data from preliminary clinical trials.

<乌鸦传媒>Melanoma Tx Ups Survival, but Very Pricey

LAS VEGAS -- The oral BRAF inhibitor vemurafenib (Zelboraf) increased survival in patients with metastatic melanoma, but the cost may not justify its use in a state Medicaid program, an analysis suggested.

鈥�

15